Navigation Links
Emerging Markets Present Challenge for Medical Device Companies Outsourcing Clinical Activities
Date:9/6/2013

CHAPEL HILL, N.C., Sept. 6, 2013 /PRNewswire/ -- It's no secret that the medical device sector sees emerging markets such as China and Brazil as their best opportunity for top-line growth over the next decade.

But to ensure their expansion into emerging markets, device companies will have to conduct more clinical activities in these high-growth countries so they can market their new products there. While some of the largest device companies have opened or announced plans to locate large research facilities in places like China and India, other organizations are using CROs or establishing small beach-head offices and using local resources.

Outsourcing is one of the tactics clinical leaders are using to expand their clinical programs into emerging markets. To help clinical leadership evaluate their organization's approach to outsourcing clinical activities, research and consulting leader Best Practices, LLC conducted a primary research study that analyzes factors associated with outsourcing clinical trial activities, such as cost, staffing, and quality.

The study, Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies to Ensure Medical Device Success in a Global Marketplace, delivers hard-to-find external benchmarks on medical device clinical programs' presence in emerging markets, activities outsourced, staffing and budgets. Critical research objectives addressed in this study include:

  • Determine the regions where medical device organizations conduct clinical trials and percent of patients recruited annually from each region
  • Identify which Clinical Affairs activities are best suited to be outsourced or kept in-house
  • Gauge what the experience of peer device organizations has been relative to the cost of outsourcing clinical trial activities
  • Rate the value of benefits associated with outsourcing clinical trial activities 

The research found there is wide variance in the extent that medical device organizations have established clinical offices in emerging markets. But there appears to be consensus that if you have a clinical office or facility, you need to have company managers/leaders located there to guide clinical efforts.

"If your organization can support it, I'm a firm believer that having somebody on the ground is much more efficient operationally than trying to manage it remotely. But there's a cost benefit there or a cost that comes with having an infrastructure in those areas and it really would depend on the size of the company and the volume of work that they could do," said a clinical affairs director who participated in the study.

Research participants included 13 executives and managers from 11 medical device companies across a wide variety of therapeutic areas and product classes

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1232.htm.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Up to Sixty Percent of Surveyed U.S. Managed Care Organization Directors Expect to Cover Key Emerging Therapies for Parkinsons Disease on Their Largest Commercial Plan
2. Device Sector Facing Medical Education Challenges as Industry Continues Expansion into Emerging Markets
3. Frost & Sullivan Analyzes Emerging Opportunities for Stakeholders in the Transforming Healthcare Industry
4. The Emerging Eastern European Market For Interventional Cardiology Devices Will Grow To $282 Million By 2021
5. In Terms of Effect on Overall Survival, Current and Emerging Therapies Have No Advantage Over Avastin/FOLFIRI in the Treatment of Second-Line Metastatic Colorectal Cancer, According to Clinical Data and Thought Leader Opinion
6. For Moderate to Severe Psoriasis, Thought Leaders Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
7. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
8. Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show
9. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
10. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
11. NextDocs Launches QuickStart for Emerging Growth Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray product ... a healthy CAGR during the forecast period Mobile ... the global digital mobile X-Ray devices market, which is estimated ... 2017, expanding at a CAGR of 7% over the forecast ... opportunity of more than US$ 100 Mn in 2017 over ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... 2017 , ... The Patient Advocacy Community of The Beryl Institute presented Eve ... Ravich Patient Advocacy Award in recognition of her extraordinary contributions to the field ... at The Beryl Institute’s annual Patient Experience Conference on March 20 in ...
(Date:4/21/2017)... Sterling, VA (PRWEB) , ... April 21, 2017 ... ... hosting its first weeklong campaign, AWARE: A Week of Addiction and Recovery Education, ... emerging evidence in treating and preventing substance use disorders. , The mission ...
(Date:4/21/2017)... Malvern, Worcestershire, UK (PRWEB) , ... April 21, ... ... Queen’s Award for Enterprise in the category of International Trade, the UK’s most ... performance in international trade, which represents 95% of total revenues and has grown ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Westside ... experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become one ... to help my numerous clients over the years with all their dental needs,” said ...
(Date:4/21/2017)... ... 21, 2017 , ... Federal mandate, fines, controversy, questions about ... Obamacare program that most Republicans love to hate and Texas Agriculture Commissioner Sid ... , Like Obamacare, the Miller program centers upon a federal mandate. ...
Breaking Medicine News(10 mins):